US Archives - Page 27 of 119 - European Medical Journal

Methotrexate Intolerance Not Tied to Administration Route

In a new cross-sectional study, methotrexate intolerance in patients with rheumatoid arthritis (RA) was not significantly associated with dosing frequency or route of administration, according to new findings.

Gut–Skin Axis Targeted by Herbal Remedy in Atopic Dermatitis Trial

A randomized controlled trial has found that Bojungikgi-tang (BJT), a traditional East Asian herbal medicine, significantly improved symptoms of anorexia and atopic dermatitis (AD) while altering the gut microbiome in affected patients.

Switching Early to Camizestrant May Delay Progression: ASCO 2025

Switching to camizestrant upon detection of an ESR1 mutation, before clinical disease progression, may extend progression-free survival (PFS) for patients with hormone receptor (HR)-positive, HER2-negative advanced breast cancer, according to results from the Phase III SERENA-6 trial.

Mood Symptoms Linked to Poorer Progressive Supranuclear Palsy Outcomes

Depression and anxiety, not motor decline, are the strongest predictors of quality of life in patients with progressive supranuclear palsy (PSP), according to a new study that underscores the pressing need for comprehensive symptom management beyond traditional motor assessments.

Why Female Shift Workers Face Higher Asthma Risk

Female night shift workers may face a significantly increased risk of developing asthma, according to a new study that analyzed data from more than 280,000 participants.

The Rise of Onco-Rheumatology: A New Era Begins

As cancer therapies evolve and autoimmune diseases become more prevalent, the intersection of oncology and rheumatology, onco-rheumatology, is emerging as a critical field demanding transdisciplinary care.

Ceftazidime-Avibactam Resistance Emerges During Therapy

In a concerning development for infectious disease management, researchers have identified the emergence of ceftazidime-avibactam resistance in Klebsiella pneumoniae during the course of therapy, driven by novel mutations in KPC enzymes.

JAK Inhibitor Acne Common in Middle-Aged IBD

Acne has emerged as a frequent and clinically relevant side effect in patients with inflammatory bowel disease (IBD) treated with JAK inhibitors, according to the largest international retrospective cohort study to date on this adverse event.

ATS 2025 Interview: Raed Dweik

As a physician-scientist, studying the pulmonary circulation has given me the opportunity to align my clinical practice in…

ATS 2025 Interview: Jesse Roman

In my view, the best patient care enterprises are those that efficiently integrate research and education. In following the Flexnerian…